King & Spalding Represented TVM Capital On Its Investment In Boston Oncology Arabia
King & Spalding Represented TVM Capital On Its Investment In Boston Oncology Arabia
King & Spalding provided legal counsel to TVM Capital Healthcare in its $35 million investment in Boston Oncology Arabia, a Saudi Arabian biogeneric drug manufacturer and distributor. This strategic investment aims to expand TVM Capital Healthcare’s presence in Saudi Arabia.
The King & Spalding team involved in the transaction included lawyers from Riyadh, Dubai, Atlanta, and London offices. The team was led by Nabil A. Issa (Managing Partner) and Martin Hunt (Partner) and were supported by Sunandini Das (Counsel), Senior Associates Saud Aldawsari and Mohammed Basama, as well as Associates Jamie Kershaw, Husni Al Far, and Michael Nunnally (based in Atlanta) and Katie Munro.
Headquartered in Dubai, TVM Capital Healthcare specializes in investment management within the healthcare sector. Its strategy focuses on injecting equity capital into healthcare companies and actively participating as a strategic partner by injecting equity capital and acting as a highly active shareholder.
